Study Evaluating EKB-569 in Advanced Colorectal Cancer.

Trial Profile

Study Evaluating EKB-569 in Advanced Colorectal Cancer.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Aug 2009

At a glance

  • Drugs Pelitinib (Primary)
  • Indications Colorectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top